Application of CAR-T cell therapy in orthopedics: From bone malignancies to non-malignant musculoskeletal disorders. [PDF]
Que Y +7 more
europepmc +1 more source
Patient-specific midbrain organoids with CRISPR correction recapitulate neuronopathic Gaucher disease phenotypes and enable evaluation of novel therapies. [PDF]
Lin Y +15 more
europepmc +1 more source
mRNA CAR T cells promote tolerable, tunable therapy in preclinical high grade glioma models. [PDF]
Pomaville M, Foster JB.
europepmc +1 more source
Bioengineered cell therapies for pediatric solid tumors: unmet needs and a measurement-integrated approach. [PDF]
Sandoval-Castellanos AM +4 more
europepmc +1 more source
Clinical, biochemical and molecular spectrum of acute neuronopathic type 2 Gaucher disease from India. [PDF]
Sheth J +14 more
europepmc +1 more source
Case Report: Early introduction of anti-GD2 immunotherapy during induction chemotherapy in high-risk neuroblastoma: two pediatric cases. [PDF]
Hu T +6 more
europepmc +1 more source
Changes in the Metabolism of GD2-Specific Murine CAR-T Cells After Co-Culturing with Melanoma. [PDF]
Bulygin A +11 more
europepmc +1 more source
SIRPα ablated iPSC-derived macrophages resist hypophagia and enhance mAb-dependent and CAR-mediated cytotoxicity of solid tumors. [PDF]
Smith PR +9 more
europepmc +1 more source
Efficacy of CAR-T-Cell-Based Immunotherapies in Patients With Glioma: A Systematic Review and Meta-Analysis. [PDF]
Zadeh SMM +10 more
europepmc +1 more source
Mesenchymal transition as a potential mechanism of late immune evasion in neuroblastoma: a case of late relapse after allogeneic hematopoietic stem cell transplantation. [PDF]
Hu H +7 more
europepmc +1 more source

